Ascensia partners with Voluntis to integrate Contour BGM systems with Insulia

Ascensia Diabetes Care said it is partnering with Voluntis to connect its blood glucose monitoring systems via Bluetooth with Voluntis’ Insulia basal insulin management solution.

Through the collaborative deal, Ascensia’s Contour Next One and Contour Plus One meters will be wirelessly connected to Insulia to provide users with improved insulin management, the companies said. The integration in slated to be available during the 4th quarter of this year.

“Type 2 diabetes is a complex condition, especially for people using insulin therapy as part of their management. We’re excited to be working together with Voluntis to empower people with Type 2 diabetes by helping them to better manage their insulin treatment. This partnership helps us move further towards our ambition of providing integrated diabetes management, which we see as the future. It is our first partnership in the area of medication management, which is a critical component of integrated diabetes management, and we see Voluntis as a key partner in helping to deliver this goal. The simplicity and effectiveness of the Insulia® solution combined with the remarkable accuracy of the Contour Next One and Contour Plus One blood glucose monitoring systems, has the ability to meaningfully impact the lives of people living with diabetes, and as a result, this could lead to better outcomes,” Ascenscia CEO Michael Kloss said in a prepared statement.

“We are delighted to start this collaboration with Ascensia in order to provide a seamless combination of Bluetooth-enabled blood glucose monitoring systems with digital insulin therapy optimization. Joining forces will help us simplify how people manage their blood sugars from end-to-end so they can vastly improve their quality of life,” Voluntis CEO Pierre Leurent said in a press release.

NEXT: Integrity Applications reports high clinical accuracy in GlucoTrack study